A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to compare the relative bioavailability of JNJ‐64565111 between subcutaneous (SC) administrations in the upper arm versus the abdomen, and between SC administrations in the thigh versus the abdomen in otherwise healthy overweight/obese participants (Part A) and to assess the gastrointestinal tolerability of JNJ‐64565111 following a dose titration in otherwise healthy obese participants at 6 weeks (Part B).
Epistemonikos ID: 1e9d0d3791e274f1d4719f7f0d96e2022a0d22b2
First added on: May 21, 2024